International Experts Discuss Improvements to Cancer Screening and Cancer Patient Care Systems in Latvia
International Experts Discuss Improvements to Cancer Screening and Cancer Patient Care Systems in Latvia 12–13 May 2026 LLUMINAS On 12–13 May, international experts from the Erasmus University Medical Center in the Netherlands visited Latvia to discuss the development of improvements in cancer screening and oncology patient healthcare, as well as data-driven healthcare planning in Latvia. […]
University of Latvia Hosts TOGAS Project Closing Consortium Meeting in Riga
University of Latvia Hosts TOGAS Project Closing Consortium Meeting in Riga Gastric Cancer Prevention Closing Consortium Meeting On 11 May 2026, the Closing Consortium Meeting of the TOGAS (Towards Gastric Cancer Screening Implementation in the European Union) project took place at the University of Latvia (LU), the House of Science in Riga, Latvia. The meeting […]
Strengthening Synergy: Latvian Partners Unite to Advance Cancer Screening Excellence
Strengthening Synergy: Latvian Partners Unite to Advance Cancer Screening Excellence Cancer Screening On January 29, the RSU Anatomy Museum in Riga hosted a key meeting for the Latvian partners of the EUCanScreen Joint Action (Implementation of Cancer Screening Programmes). The event brought together representatives from Riga Stradins University (RSU), the University of Latvia, the Centre […]
Young Voices in Science: Tackling Early-Onset Colorectal Cancer
Young Voices in Science: Tackling Early-Onset Colorectal Cancer Research On Early-Onset Colorectal Cancer Colorectal Screening WHO/Europe published a feature highlighting research on the increasing incidence of colorectal cancer among younger populations. The article focuses on emerging trends and the need to better understand risk factors and disease patterns. Click here to find out more details
Latvia Improves Cancer Screening Programme Evaluation by Refining Indicator Methodology and Data Visualisations
Latvia Improves Cancer Screening Programme Evaluation by Refining Indicator Methodology and Data Visualisations Ensuring a More Consistent and Comparable Framework for Programme Evaluation. The Centre for Disease Prevention and Control of Latvia (CDPC) The Centre for Disease Prevention and Control of Latvia (CDPC) has refined its approach to monitoring and evaluating nationally organised cancer screening […]
PHEG Sub-Group on Cancer (7 May 2026)
PHEG Sub-Group on Cancer (7 May 2026) European Commission Cancer Sub-Group Meeting Agenda The Event The European Commission published the agenda for the Public Health Expert Group sub-group on cancer meeting scheduled for 7 May 2026. The update provides access to the official agenda document and reflects ongoing work on cancer within EU public health […]
Incidental Findings in Lung Cancer Screening: Managing Interstitial Lung Abnormalities (ILA)
Incidental Findings in Lung Cancer Screening Managing Interstitial Lung Abnormalities (ILA) Significant Incidental Findings As the National Lung Cancer Screening Programme in the Czech Republic continues to evolve, the focus is expanding beyond tumor detection to the management of significant incidental findings. Specifically, the Czech screening framework is currently developing recommended clinical guidelines for Interstitial […]
Turn Your Back on Cancer
Turn Your Back on Cancer November 2025 – March 2026 About the “Turn Your Back on Cancer” Campaign The campaign ran from November 2025 to March 2026 and aimed at raising awareness of the possibilities of population-based cancer screening programmes. Communication Strategy A comprehensive communication strategy was implemented to integrate the topic of cancer screening […]
Launch of the WHO Classification of Tumours Evidence Explorer Tool
Launch of the WHO Classification of Tumours Evidence Explorer Tool A New Digital Resource to Support Evidence-Based Tumour Classification The Event IARC announces the launch of the WHO Classification of Tumours Evidence Explorer. The event will take place on 25 June 2026. The Tool The tool aims to improve transparency and rigour in tumour classification […]
IARC Monographs Evaluation of the Carcinogenicity of Tris (Chloropropyl) Phosphate, Butyraldehyde and Cumyl Hydroperoxide
IARC Monographs Evaluation of the Carcinogenicity of Tris (Chloropropyl) Phosphate, Butyraldehyde and Cumyl Hydroperoxide IARC Issues New Hazard Classifications for Three High-Volume Industrial Chemicals Evaluation IARC announces the evaluation of tris (chloropropyl) phosphate, butyraldehyde and cumyl hydroperoxide. Tris (chloropropyl) phosphate is classified as probably carcinogenic to humans, while the other two substances are classified as […]
